CORTEVA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.8 USD | +1.56% |
|
+1.93% | +14.36% |
| Apr. 17 | Goldman Sachs Adjusts Corteva Price Target to $59 From $56 | MT |
| Apr. 16 | Oppenheimer Raises Price Target on Corteva to $67 From $62, Outperform Rating Kept | MT |
Financials (USD)
| Sales 2024 * | 17.59B | Sales 2025 * | 18.36B | Capitalization | 38.3B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.41B | Net income 2025 * | 1.81B | EV / Sales 2024 * | 2.15 x |
| Net cash position 2024 * | 508M | Net cash position 2025 * | 1.03B | EV / Sales 2025 * | 2.03 x |
| P/E ratio 2024 * |
27
x | P/E ratio 2025 * |
20.7
x | Employees | 22,500 |
| Yield 2024 * |
1.22% | Yield 2025 * |
1.33% | Free-Float | 99.91% |
More Fundamentals
* Assessed data
More news
Latest transcript on Corteva, Inc.
More recommendations
More press releases
More news
| 1 day | +1.56% | ||
| 1 week | +1.93% | ||
| Current month | -4.98% | ||
| 1 month | +0.24% | ||
| 3 months | +20.18% | ||
| 6 months | +7.54% | ||
| Current year | +14.36% |
1 week
53.19
54.84
1 month
53.1958.18
Current year
44.0158.18
1 year
43.2262.10
3 years
40.6068.43
5 years
20.3868.43
10 years
20.3868.43
| Managers | Title | Age | Since |
|---|---|---|---|
Charles Magro
CEO | Chief Executive Officer | 54 | 21-10-31 |
Dave Anderson
DFI | Director of Finance/CFO | 74 | 21-04-11 |
Sam Eathington
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-05-06 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gregory Page
CHM | Chairman | 72 | - |
David Everitt
BRD | Director/Board Member | 71 | 21-03-18 |
| Director/Board Member | 53 | 19-06-24 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.59% | 4 M€ | +20.15% | ||
| 1.02% | 18 M€ | +1.40% | - | |
| 0.99% | 22 M€ | -15.17% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 54.8 | +1.56% | 2,052,666 |
| 24-04-18 | 53.96 | +0.80% | 1,614,887 |
| 24-04-17 | 53.53 | +0.39% | 2,656,525 |
| 24-04-16 | 53.32 | -0.65% | 2,742,839 |
| 24-04-15 | 53.67 | -0.17% | 2,709,524 |
Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT
More quotes
Corteva, Inc. specializes in the manufacturing and marketing of agricultural and phytosanitary products. Net sales break down by activity as follows:
- production of seed and grain (51.4%): mainly corn seeds (66.2% of net sales) and soybeans (20.2%);
- manufacture of crop protection products (48.6%): herbicides (54.2% of net sales), insecticides (21.6%), fungicides (17.1%) and other 7.1%).
At the end of 2022, the group had 85 production sites worldwide.
Net sales are distributed geographically as follows: the United States and Canada (47.5%), Latin America (25.5%), Europe/Middle East/Africa (18.6%), and Asia/Pacific (8.4%).
Sector
Agricultural Chemicals
Calendar
2024-04-26
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
54.8
USD
Average target price
62.45
USD
Spread / Average Target
+13.96%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.36% | 37.71B | |
| -.--% | 10.93B | |
| -8.30% | 7.11B | |
| +5.61% | 6.74B | |
| -2.75% | 6.01B | |
| -5.56% | 5.6B | |
| +37.95% | 5.28B | |
| -20.36% | 5.05B | |
| +21.61% | 4.54B | |
| -17.11% | 4.3B |
- Stock Market
- Equities
- CTVA Stock
